IWM
MRNA icon

IHT Wealth Management’s Moderna MRNA Stock Holding History

IHT Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,649
Closed -$200K – 1006
2023
Q2 		$200K Buy
1,649
+37
+2% +$4.94K 0.01% 889
2023
Q1 		$248K Buy
1,612
+32
+2% +$5.28K 0.01% 768
2022
Q4 		$284K Sell
1,580
-869
-35% -$142K 0.02% 679
2022
Q3 		$290K Buy
2,449
+149
+6% +$22.6K 0.02% 636
2022
Q2 		$329K Buy
2,300
+10
+0.4% +$1.43K 0.03% 502
2022
Q1 		$394K Sell
2,290
-1,399
-38% -$236K 0.03% 489
2021
Q4 		$937K Sell
3,689
-513
-12% -$150K 0.07% 275
2021
Q3 		$1.62M Sell
4,202
-183
-4% -$67.5K 0.13% 153
2021
Q2 		$1.03M Buy
4,385
+1,854
+73% +$331K 0.07% 312
2021
Q1 		$331K Buy
+2,531
New +$367K 0.02% 598
2020
Q3 		– Sell
-3,649
Closed -$234K – 678
2020
Q2 		$234K Buy
+3,649
New +$200K 0.03% 476

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

IHT Wealth Management's MRNA Position: Q3 2023 in Review

IHT Wealth Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,649 shares — an estimated $200K sold.

IHT Wealth Management first reported a position in MRNA in Q2 2020 and held it in 11 quarters. The position peaked at $1.62M in Q3 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • IHT Wealth Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • IHT Wealth Management sold 1,649 Moderna shares in Q3 2023, an estimated $200K.
  • IHT Wealth Management first reported a position in Moderna in Q2 2020 and held it in 11 quarters.
  • IHT Wealth Management's Moderna position peaked at $1.62M in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on IHT Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.